4Maher ER, Yates JR, Harries R, et al. Clinical features and natural history of von Hippel-Lindau disease. Q J Med, 1990, 77∶1151-1163.
5Latif F, Tory K, Gnarra J, et al. Identifications of the von Hippel-Lindau disease tumor suppressor gene. Science, 1993, 260∶1317-1320.
6Zbar B, Kishida T, Chen F, et al. Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe and Japan. Hum Mutat, 1996, 8∶348-357.
7Ashida S, Okuda H, Chikazawa M, et al. Detection of circulating cancer cells with von Hippel-Lindau gene mutation in peripheral blood of patients with renal cell carcinoma. Clin Cancer Res, 2000, 6∶3817-3822.
8Lamiell JM, Salazar FG, Hsia YE. von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine(Baltimore), 1989, 68∶1-29.
9Renbaum P, Duh FM, Latif F, et al. Isolation and characterization of the full-length 3′ untranslated region of the human von Hippel-Lindau tumor suppressor gene. Hum Genet, 1996, 98∶666-671.
10Crossey PA, Foster K, Richards FM, et al. Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease:analysis of allele loss in VHL tumours. Hum Genet, 1994, 93∶53-58.
